TRML VS RCEL Stock Comparison

Performance

TRML
100/100

TRML returned 56.10% in the last 12 months. Based on SPY's performance of 13.09%, its performance is above average giving it a score of 100 of 100.

RCEL
100/100

RCEL returned 79.44% in the last 12 months. Based on SPY's performance of -13.88%, its performance is above average giving it a score of 100 of 100.

Volatility

TRML
67/100

TRML has had a higher than average amount of volatility over the last 12 months giving it a score of 66 of 100.

RCEL
52/100

RCEL has had a higher than average amount of volatility over the last 12 months giving it a score of 52 of 100.

Technicals

TRML

"Technicals" not found for TRML

RCEL
68/100

RCEL receives a 67 of 100 based on 14 indicators. 9 are bullish, 4 are bearish.

Earnings

TRML

"Earnings" not found for TRML

RCEL
10/100

RCEL has missed earnings 6 times in the last 20 quarters.

Profit

TRML

"Profit" not found for TRML

RCEL
10/100

Out of the last 20 quarters, RCEL has had 0 profitable quarters and has increased their profits year over year on 0 of them.

All score calculations are broken down here to help you make more informed investing decisions

Tourmaline Bio, Inc. Common Stock Summary

Nasdaq / TRML

Healthcare

Biotechnology

Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.

Avita Medical, Inc. Common Stock Summary

Nasdaq / RCEL

Healthcare

Medical - Devices

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.

Power up your portfolio